Breaking News
Sort by:
Top Post
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial for the Treatment of Rett Syndrome
Taysha Gene Therapies, a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene […]
New Study: Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X, Due to Reduced Trial Timelines and Other Factors
Medable Inc., the leading cloud platform for patient-centered drug development, today announced results from a […]
Equine Sarcoids - Visible Success with DelNS-based Immunotherapy Leads the Way Towards Cancer Therapy in Humans
Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS […]
Aelis Farma Announces Good Results From its First Administration in Humans for AEF0217, its First Drug Candidate for the Treatment of Cognitive Disorders in Down Syndrome
AELIS FARMA, a biotechnology company specializing in the treatment of brain disorders, announces today that AEF0217 […]
Avacta Announces FDA Approval of its Investigational New Drug (IND) Application for AVA6000
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and […]
Starpharma Releases Positive DEP® Cabazitaxel Phase 2 Interim Results in Prostate Cancer
Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its ongoing […]
Dutch Stem Cell Biotech Neuroplast Announces Successful Clinical Phase I Trial with Neuro-Cells® Stem Cell Treatment for Traumatic Spinal Cord Injury
Dutch clinical phase biotech company Neuroplast and Hospital Nacional de Parapléjicos de Toledo in Spain, today […]
New Phase 3 Analyses Show That a Single Dose of REGEN-COV® (casirivimab and imdevimab) Provides Long-term Protection Against COVID-19
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced additional positive results from a Phase 3 trial jointly run with the […]
GSK Announces Positive Phase III Efficacy and Safety Data for Daprodustat in Patients with Anaemia Due to Chronic Kidney Disease
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced positive results from the Phase III ASCEND (Anaemia Studies in […]
PDC*line Pharma Opens Last Cohort of PDC-LUNG-101 Clinical Trial
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable […]
SomaLogic Announces Strategic Collaboration with University Hospitals Cleveland Medical Center to Treat Diabetic Patients at High Risk of Cardiovascular Disease
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more